Medical News

RSS

IOF, PAOS invite medical professionals to attend CME-accredited meeting in Jordan

The International Osteoporosis Foundation (IOF) and the Pan Arab Osteoporosis Society (PAOS) invite medical professionals to attend their joint meeting at the King Hussein Bin Talal Convention Centre, Dead Sea, Jordan, from September 27 to October 1, 2012.

6 Aug 2012

Uganda Ebola virus outbreak under control, WHO says

The Ebola virus outbreak that began last month in Uganda is under control, with health agencies having isolated the 176 people who had even slight contact with people who have contracted the virus, Joaquim Saweka, the WHO representative in Uganda, told reporters.

6 Aug 2012

FDA grants 510(k) clearance to VICTUS Femtosecond Laser Platform

Bausch + Lomb, the global eye health company, and Technolas Perfect Vision GmbH, a leading ophthalmology laser company, announced today that the VICTUS Femtosecond Laser Platform received 510(k) clearance from the U.S. Food and Drug Administration.

6 Aug 2012

ABP, Alembic enter into development and license agreement for Accu-Break tablet technologies

Accu-Break Pharmaceuticals, Inc. announced today that it has entered into a development and license agreement with Alembic Pharmaceuticals Limited of Gujarat, India to develop new brand products that will use ABP's innovative Accu-Break tablet technologies.

6 Aug 2012

New research center to expedite study of gene transfer approach

In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.

6 Aug 2012

Cholera affecting refugees in Eastern Congo, MSF reports

"The first case of cholera has emerged among thousands of people in an impromptu refugee camp in eastern Congo who fled fighting between a new rebel group and government forces backed by U.N. peacekeepers," according to Medecins Sans Frontieres (MSF), the Associated Press/Washington Post reports (Muhumuza, 8/3).

6 Aug 2012

Common anti-angina drug may help protect the heart against carbon monoxide poisoning

An international research team, led from the University of Leeds, has found that a common anti-angina drug could help protect the heart against carbon monoxide poisoning.

6 Aug 2012

Rexahn announces completion of RX-3117 exploratory Phase I clinical trial in cancer patients

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.

6 Aug 2012

Political cartoon: 'Fear Itself'

Kaiser Health News provides a fresh take on health policy developments with "Fear Itself" by Steve Kelley.

6 Aug 2012

Premier healthcare alliance awards new agreements for mobility aids

The Premier healthcare alliance today announced new agreements for mobility aids have been awarded.

6 Aug 2012

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.

6 Aug 2012

Blog examines impact of adolescent pregnancy in South Asia

As part of its monthly series Stories Behind the Statistics, "guest edited by FHI 360 on behalf of USAID'S IYWG, which provides technical leadership to improve the reproductive and sexual health of young people," the Bill & Melinda Gates Foundation's "Impatient Optimists" blog features a story by Gaj Bahadur Gurung, program coordinator for the National Federation of Women Living with HIV and AIDS in Nepal, who discusses the impact of adolescent pregnancy on girls and young women in South Asia.

6 Aug 2012

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

About two years ago NeuroMetrix changed their focus from general purpose devices, used to perform nerve conduction tests, to devices designed to specifically address diabetic peripheral neuropathy or DPN.

6 Aug 2012

Head trauma in older adults over a weekend more deadly than during the week

A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.

6 Aug 2012

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).

6 Aug 2012

Nanobiotix, PharmaEngine partner to develop NBTXR3 for cancer

French Nanobiotix S.A. announced today that it entered into a strategic partnership with PharmaEngine, Inc. for the rapid development of NBTXR3, the lead product from the NanoXray pipeline of Nanobiotix.

6 Aug 2012

Eliza receives U.S. patent allowance for Complex Acoustic Resonance Speech Analysis System

Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.

6 Aug 2012

Mylan receives final FDA approval for generic Amidate ANDA

Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Etomidate Injection USP, 2 mg/mL packaged in 40 mg/20 mL single-use vials.

6 Aug 2012

First Edition: August 6, 2012

Today's headlines include a progress a report about health insurance exchanges as well as news from the campaign trail.

6 Aug 2012

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

6 Aug 2012

Medical News

IOF, PAOS invite medical professionals to attend CME-accredited meeting in Jordan

Uganda Ebola virus outbreak under control, WHO says

FDA grants 510(k) clearance to VICTUS Femtosecond Laser Platform

ABP, Alembic enter into development and license agreement for Accu-Break tablet technologies

New research center to expedite study of gene transfer approach

Cholera affecting refugees in Eastern Congo, MSF reports

Common anti-angina drug may help protect the heart against carbon monoxide poisoning

Rexahn announces completion of RX-3117 exploratory Phase I clinical trial in cancer patients

Political cartoon: 'Fear Itself'

Premier healthcare alliance awards new agreements for mobility aids

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Blog examines impact of adolescent pregnancy in South Asia

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

Head trauma in older adults over a weekend more deadly than during the week

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

Nanobiotix, PharmaEngine partner to develop NBTXR3 for cancer

Eliza receives U.S. patent allowance for Complex Acoustic Resonance Speech Analysis System

Mylan receives final FDA approval for generic Amidate ANDA

First Edition: August 6, 2012

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News